This is a preview of subscription content, log in via an institution to check access.
References
Ambros, I. M.; Ambros, P. F.; Strehl, S., et al. MIC2 is a specific marker for Ewing’s sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing’s sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67:1886–1893; 1991.
Aurias, A.; Rimbaut, C.; Buffe, D., et al. Chromosomal translocation in Ewing’s sarcoma. N. Engl. J. Med. 309:496–497; 1983.
Ayala, A. G.; Ro, J. Y.; Teot, L. A., et al. Neoplasms and tumor-like lesions of bone. In: Silverberg, S. G.; DeLellis, R. A.; Frable, W. J., eds. Principles and practice of surgical pathology and cytopathology. 3rd ed. New York: Churchill-Livingstone, Inc.; 1997:863–941.
Coffin, C. M.; Dehner, L. P. The soft tissues. In: Stocker, J. T.; Dehner, L. P., eds. Pediatric pathology. Philadelphia, PA: J. B. Lippincott Co.; 1992:1091–1132.
Dehner, L. P. Primitive neuroectodermal tumor and Ewing’s Sarcoma. Am. J. Surg. Pathol. 17:1–13; 1993.
Delattre, O.; Zucman, J.; Melot, T., et al. The Ewing family of tumors. A subgroup of small-round-cell tumors defined by specific chimeric transcripts. N. Engl. J. Med. 331:294–299; 1994.
Delattre, O.; Zucman, J.; Plougastel, B., et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162–165; 1992.
Enzinger, F. M.; Weiss, S. W. Soft tissue tumors. 3rd ed. St. Louis, MO: Mosby; 1995.
Fletcher, J. A. Cytogenetic aberrations in malignant soft tissue tumors. In: Fenoglio-Preiser, C. M., ed. Advances in pathology and laboratory medicine. Vol. 4. St. Louis, MO: Mosby; 1991:235–246.
Gelin, C.; Aubrit, F.; Phalipon, A., et al. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J. 8:3253–3259; 1989.
Klemsz, M. J.; Maki, R. A.; Papaynnopoulou, T., et al. Characterization of the ets oncogene family member, fli-1. J. Biol. Chem. 268:5769–5773; 1993.
Lessnick, S. L.; Braun, B. S.; Denny, C. T., et al. Multiple domains mediate transformation by the Ewing’s sarcoma EWS/FLI-1 fusion gene. Oncogene 10:423–431; 1995.
Levy, R.; Dilley, J.; Fox, R. I., et al. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc. Natl. Acad. Sci. USA 76:6552–6556; 1979.
Ouchida, M.; Ohno, T.; Fujimura, Y., et al. Loss of tumorigenicity of Ewing’s sarcoma cells expressing antisence RNA to EWS-fusion transcripts. Oncogene 11:1049–1054; 1995.
Scotlandi, K.; Serra, M.; Marana, M. C., et al. Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing’s sarcoma and peripheral neuroectodermal tumor. Hum. Pathol. 27:408–416; 1996.
Turc-Carel, C.; Aurias, A.; Mugneret, F., et al. Chromosomes in Ewing’s sarcoma. I. An evaluation of 85 cases and remarkable consistency of t(11:22)(q24↕2). Cancer Genet. Cytogenet. 32:229–238; 1988.
Whang-Peng, J.; Triche, T. J.; Kuntsen, T., et al. Chromosome translocation in peripheral neuroepithelioma. N. Engl. J. Med. 311:584–585; 1984.
Wold, L. E. Neoplastic, metabolic, and inflammatory disorders of the bones and joints. In: Stocker, J. T.; Dehner, L. P. Pediatric pathology. Philadelphia, PA: J. B. Lippincott Co.; 1992:1223–1260.
Zucman, J.; Melot, T.; Desmaze, C., et al. Combinatorial generation of variable fusion proteins in the Ewing family of tumors. EMBO J. 12:4481–4487; 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Horiguchi, H., Matsui, M., Ohtsubo, R. et al. Establishment and characterization of a typical primitive neuroectodermal tumor cell line. In Vitro Cell.Dev.Biol.-Animal 34, 439–442 (1998). https://doi.org/10.1007/s11626-998-0074-1
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11626-998-0074-1